Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Bradykinesia in dystonic hand tremor: kinematic analysis and clinical rating

P. Matejicka, S. Kajan, J. Goga, I. Straka, M. Balaz, S. Janovic, M. Minar, P. Valkovic, M. Hajduk, Z. Kosutzka

. 2024 ; 18 (-) : 1395827. [pub] 20240613

Status not-indexed Language English Country Switzerland

Document type Journal Article

INTRODUCTION: Bradykinesia is an essential diagnostic criterion for Parkinson's disease (PD) but is frequently observed in many non-parkinsonian movement disorders, complicating differential diagnosis, particularly in disorders featuring tremors. The presence of bradykinetic features in the subset of dystonic tremors (DT), either "pure" dystonic tremors or tremors associated with dystonia, remains currently unexplored. The aim of the current study was to evaluate upper limb bradykinesia in DT patients, comparing them with healthy controls (HC) and patients with PD by observing repetitive finger tapping (FT). METHODS: The protocol consisted of two main parts. Initially, the kinematic recording of repetitive FT was performed using optical hand tracking system (Leap Motion Controller). The values of amplitude, amplitude decrement, frequency, frequency decrement, speed, acceleration and number of halts of FT were calculated. Subsequently, three independent movement disorder specialists from different movement disorders centres, blinded to the diagnosis, rated the presence of FT bradykinesia based on video recordings. RESULTS: Thirty-six subjects participated in the study (12 DT, 12 HC and 12 early-stage PD). Kinematic analysis revealed no significant difference in the selected parameters of FT bradykinesia between DT patients and HC. In comparisons between DT and PD patients, PD patients exhibited bigger amplitude decrement and slower FT performance. In the blinded clinical assessment, bradykinesia was rated, on average, as being present in 41.6% of DT patients, 27.7% of HC, and 91.7% of PD patients. While overall inter-rater agreement was moderate, weak agreement was noted within the DT group. DISCUSSION: Clinical ratings indicated signs of bradykinesia in almost half of DT patients. The objective kinematic analysis confirmed comparable parameters between DT and HC individuals, with more pronounced abnormalities in PD across various kinematic parameters. Interpretation of bradykinesia signs in tremor patients with DT should be approached cautiously and objective motion analysis might complement the diagnostic process and serve as a decision support system in the choice of clinical entities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012540
003      
CZ-PrNML
005      
20240726151359.0
007      
ta
008      
240723e20240613sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnhum.2024.1395827 $2 doi
035    __
$a (PubMed)38938290
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Matejicka, Peter $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
245    10
$a Bradykinesia in dystonic hand tremor: kinematic analysis and clinical rating / $c P. Matejicka, S. Kajan, J. Goga, I. Straka, M. Balaz, S. Janovic, M. Minar, P. Valkovic, M. Hajduk, Z. Kosutzka
520    9_
$a INTRODUCTION: Bradykinesia is an essential diagnostic criterion for Parkinson's disease (PD) but is frequently observed in many non-parkinsonian movement disorders, complicating differential diagnosis, particularly in disorders featuring tremors. The presence of bradykinetic features in the subset of dystonic tremors (DT), either "pure" dystonic tremors or tremors associated with dystonia, remains currently unexplored. The aim of the current study was to evaluate upper limb bradykinesia in DT patients, comparing them with healthy controls (HC) and patients with PD by observing repetitive finger tapping (FT). METHODS: The protocol consisted of two main parts. Initially, the kinematic recording of repetitive FT was performed using optical hand tracking system (Leap Motion Controller). The values of amplitude, amplitude decrement, frequency, frequency decrement, speed, acceleration and number of halts of FT were calculated. Subsequently, three independent movement disorder specialists from different movement disorders centres, blinded to the diagnosis, rated the presence of FT bradykinesia based on video recordings. RESULTS: Thirty-six subjects participated in the study (12 DT, 12 HC and 12 early-stage PD). Kinematic analysis revealed no significant difference in the selected parameters of FT bradykinesia between DT patients and HC. In comparisons between DT and PD patients, PD patients exhibited bigger amplitude decrement and slower FT performance. In the blinded clinical assessment, bradykinesia was rated, on average, as being present in 41.6% of DT patients, 27.7% of HC, and 91.7% of PD patients. While overall inter-rater agreement was moderate, weak agreement was noted within the DT group. DISCUSSION: Clinical ratings indicated signs of bradykinesia in almost half of DT patients. The objective kinematic analysis confirmed comparable parameters between DT and HC individuals, with more pronounced abnormalities in PD across various kinematic parameters. Interpretation of bradykinesia signs in tremor patients with DT should be approached cautiously and objective motion analysis might complement the diagnostic process and serve as a decision support system in the choice of clinical entities.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kajan, Slavomir $u Institute of Robotics and Cybernetics, Faculty of Electrical Engineering and Informatics, Slovak University of Technology in Bratislava, Bratislava, Slovakia
700    1_
$a Goga, Jozef $u Institute of Robotics and Cybernetics, Faculty of Electrical Engineering and Informatics, Slovak University of Technology in Bratislava, Bratislava, Slovakia
700    1_
$a Straka, Igor $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Balaz, Marek $u 1st Department of Neurology, St. Anne's University Hospital, Masaryk University, Brno, Czechia $u Central European Institute of Technology (CEITEC), Brno, Czechia
700    1_
$a Janovic, Simon $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Minar, Michal $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Valkovic, Peter $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia $u Institute of Normal and Pathological Physiology, Center of Experimental Medicine, Slovak Academy of Sciences (SAS), Bratislava, Slovakia
700    1_
$a Hajduk, Michal $u Department of Psychology, Faculty of Arts, Comenius University, Bratislava, Slovakia $u Centre for Psychiatric Disorders Research, Science Park, Comenius University in Bratislava, Bratislava, Slovakia $u Department of Psychiatry, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Kosutzka, Zuzana $u 2nd Department of Neurology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
773    0_
$w MED00174547 $t Frontiers in human neuroscience $x 1662-5161 $g Roč. 18 (20240613), s. 1395827
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38938290 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151352 $b ABA008
999    __
$a ok $b bmc $g 2125401 $s 1224403
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 18 $c - $d 1395827 $e 20240613 $i 1662-5161 $m Frontiers in human neuroscience $n Front Hum Neurosci $x MED00174547
LZP    __
$a Pubmed-20240723

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...